- Multiple SBIR/STTR Submission Deadlines Quickly Approaching -
ROCKVILLE, MARYLAND, March 25, 2013 – BioHealth Innovation, Inc. (BHI), a regional private-public partnership focusing on commercializing market-relevant biohealth innovations and increasing access to early-stage funding in Central Maryland, announced today the launch of its Commercial Relevance Program (CRP). BHI’s CRP is designed to help life science companies navigate the complicated process of preparing applications for federal funding, inclusive of Small Business Innovation Research (SBIR), Small Business Technology Transfer (STTR), and other federal government awards.
“The federal grant application process can be very complex. Based on 2012 data released by the National Institutes of Health (NIH), Maryland ranks 32nd out of 50 states with regard to SBIR award success rates. We would like to improve on this – and are confident that the CRP will help companies be more successful with their submissions,” said Ethan Byler, Director, Innovation Programs, BioHealth Innovation, Inc.
“At the end of the day, it’s about helping Central Maryland companies to get the best results possible as they seek out federal grant awards as a means of non-dilutive funding,” he added. The CRP incorporates a pre-proposal review by knowledgeable BHI staff and advisors prior to a life science company’s submission of a full proposal. Through this review process, applicants will receive a set of recommendations and tips for troubleshooting their proposal for federal funding.
Interested life science companies in Central Maryland should contact BHI today for more information. The following federal agency SBIR/STTR deadlines are fast approaching:
NIH SBIR/STTR Deadline - April 5, 2013 - http://grants.nih.gov/grants/funding/sbir.htm
NSF SBIR/STTR Deadline - June 11, 2013 - http://www.nsf.gov/eng/iip/sbir/index.jsp
DOD SBIR/STTR Deadline - June 26, 2013 - http://www.acq.osd.mil/osbp/sbir/sb/schedule.shtml
About BioHealth Innovation, Inc.
BioHealth Innovation, Inc., is a regional innovation intermediary focused on commercializing market-relevant bio-health innovations and increasing access to early-stage funding in Maryland. Learn more at www.biohealthinnovation.org.
# # #
Media contact:
Rich Bendis, President & CEO, 301-637-6439, This email address is being protected from spambots. You need JavaScript enabled to view it.
